TY - JOUR
KW - Analgesics, Opioid/therapeutic use/urine
KW - Clinical Competence
KW - Cooperative Behavior
KW - Drug Monitoring/methods
KW - False Negative Reactions
KW - False Positive Reactions
KW - Health Knowledge, Attitudes, Practice
KW - Humans
KW - Interdisciplinary Communication
KW - Opioid-Related Disorders/diagnosis/urine
KW - Patient Compliance
KW - Physicians, Family
KW - Predictive Value of Tests
KW - Substance Abuse Detection/methods
KW - Surveys and Questionnaires
KW - Urinalysis
AU - G. M. Reisfield
AU - F. J. Webb
AU - R. L. Bertholf
AU - P. A. Sloan
AU - G. R. Wilson
A1 - 
AB - OBJECTIVE: To determine the proficiency in urine drug test interpretation among family medicine physicians who order these tests to monitor adherence in their patients on chronic opioid therapy. METHODS: A seven-question instrument, consisting of six, five-option, single-best-answer multiple choice questions and one yes/no question was administered to 80 family medicine physicians attending a University of Kentucky Family Medicine Review Course. We calculated frequencies and performed chi2 analyses to examine bivariate associations between urine drug test utilization and interpretive knowledge. RESULTS: The instrument was completed by 60/80 (75 percent) of eligible physicians (44 order urine drug testing; 16 do not). None of the physicians who order urine drug testing answered more than five of the seven questions correctly, and only 20 percent answered more than half correctly. Physicians who order urine drug testing performed better than physicians who do not order urine drug testing on only four of the seven questions, although there were no statistically significant differences between the groups on any question. CONCLUSIONS: Family medicine physicians who order urine drug testing to monitor their patients on chronic opioid therapy are not proficient in their interpretation. This study highlights the need for improved physician education in this area. It is imperative for physicians to work closely with certified laboratory professionals when ordering and interpreting urine drug tests.
BT - Journal of opioid management
C5 - Opioids & Substance Use; Education & Workforce
CP - 6
CY - United States
IS - 6
JF - Journal of opioid management
N2 - OBJECTIVE: To determine the proficiency in urine drug test interpretation among family medicine physicians who order these tests to monitor adherence in their patients on chronic opioid therapy. METHODS: A seven-question instrument, consisting of six, five-option, single-best-answer multiple choice questions and one yes/no question was administered to 80 family medicine physicians attending a University of Kentucky Family Medicine Review Course. We calculated frequencies and performed chi2 analyses to examine bivariate associations between urine drug test utilization and interpretive knowledge. RESULTS: The instrument was completed by 60/80 (75 percent) of eligible physicians (44 order urine drug testing; 16 do not). None of the physicians who order urine drug testing answered more than five of the seven questions correctly, and only 20 percent answered more than half correctly. Physicians who order urine drug testing performed better than physicians who do not order urine drug testing on only four of the seven questions, although there were no statistically significant differences between the groups on any question. CONCLUSIONS: Family medicine physicians who order urine drug testing to monitor their patients on chronic opioid therapy are not proficient in their interpretation. This study highlights the need for improved physician education in this area. It is imperative for physicians to work closely with certified laboratory professionals when ordering and interpreting urine drug tests.
PP - United States
PY - 2007
SN - 1551-7489; 1551-7489
SP - 333
EP - 337
EP - 
T1 - Family physicians' proficiency in urine drug test interpretation
T2 - Journal of opioid management
TI - Family physicians' proficiency in urine drug test interpretation
U1 - Opioids & Substance Use; Education & Workforce
U2 - 18290585
VL - 3
VO - 1551-7489; 1551-7489
Y1 - 2007
ER -